Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room

European Journal of Internal Medicine

Volumn 19, Issue 2, 2008, Pages 129-134

  Habib, George ^a   Nashashibi, Munir ^a   Khateeb, Arin ^a   Goichman, Sharon ^a   Kogan, Asia ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

Prolongation; Prothrombin time; Warfarin

Indexed keywords

AMIODARONE; HEMOGLOBIN; WARFARIN;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BLEEDING; CARDIOMYOPATHY; CAREGIVER; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE INCREASE; EMERGENCY WARD; FEMALE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTHROMBIN TIME; SIDE EFFECT; THROMBOEMBOLISM; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CASE-CONTROL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTHROMBIN TIME; TREATMENT OUTCOME; WARFARIN;

EID: 38949120245     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.08.006     Document Type: Article

References (18)

1. Nutescu E.A., Shapiro N.L., Chevalier A., and Amin A.N. Pharmacologic overview of current and emerging anticoagulants. Clevel Clin J Med 72 Suppl. 1 (2005) S2-S6
2. Herman D., Locatelli I., Grabnar I., Peternel P., Stegnar M., Lainsak M., et al. The influence of co-treatment of carbamazebine, amiodarone and statins on warfarin metabolism and maintenance dose. Eur J Clin Pharmacol 62 (2006) 291-296
3. Froom P., Hermoni D., and Barak M. Oral anticoagulation treatment-control, risks, benefits and informed consents. Harefuah 142 (2003) 56-60
4. Fasco M.J., Piper L.J., and Kaminsky L.S. Binding of R and S warfarin to hepatic microsomal cytochrome P-450. Arch Biochem Biophys 182 (1977) 379-389
5. Wells P.S., Holbrook A.N., Crowther N.R., and Hirsh J. interaction of warfarin with drugs and food. Ann Rheum Dis 121 (1994) 676-683
6. Rubinstein E. Comparative safety of the different macrolides. Int J Antimicrob Agents 18 Suppl 1 (2001) S71-S76
7. Chen Y., Fergusson S.S., Negishi M., and Goldstein J.A. Induction of human CYP2CP by rifampicin, hyperforin and Phenobarbital is mediated by the pregnane X receptor. J Pharmacol Exp Ther 308 (2004) 495-501
8. Kemmeren J.M., Algra A., Meijers J.C., Bouma B.N., and Grobbee D.E. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation. Thromb Haemost 87 (2002) 199-205
9. Antoniades C., Tousoulis D., Tentolouris C., Toutouza M., Marinou K., Goumas G., et al. Effects of antioxidants vitamin C and E on endothelial function and thrombosis/fibrinolysis system in smokers. Thromb Haemost 89 (2003) 990-995
10. Ifacts: Drug Interaction Facts (2006), Facts and Comparisons Version 9.0.1/2006.1.14
11. Bolton-Smith C., Price R.J., Fenton S.T., Harrington D.J., and Shearer M.J. Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of food. Br J Nutr 83 4 (2000) 389-399
12. Suttie J.W. Vitamin K and human nutrition. J Am Diet Assoc 92 (1992) 585-590
13. Schurgers L.J., Shearer M.J., Hamulyak K., Stocklin E., and Vermeer C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 104 (2004) 2682-2689
14. Kurnik D., Loebstein R., Rabinivitz H., Austerweil N., Halkin H., and Almog S. Over the counter vitamin K-1 containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K-1 depleted patients. Thromb Haemost 92 (2004) 1018-1024
15. Froom P., Miron E., and Barak M. Oral anticoagulants in the elderly. Br J Haematol 120 (2003) 526-528
16. Heimark L.D., Wienkers L., Kunze K., Gibaldi M., Eddy A.C., Trager W.F., et al. The mechanism of the interaction between amiodarone and warfarin in humans. Clin Pharmacol Ther 51 (1992) 398-407
17. Kerin N.Z., Blevins R.D., Goldman L., Faitel K., and Rubenfire M. The incidence, magnitude and time course of the amiodarone-warfarin interaction. Arch Int Med 148 (1988) 1779-1781
18. Franco V., Polanczyk C.A., Clausell N., and Rohde L.E. Role of dietary vitamin K intake in chronic oral anticoagulation: Prospective evidence from observational and randomized protocols. Am J Med 116 (2004) 651-656